| Popis: |
It has often been claimed that pharmaceutical companies adopt unethical means to grow the market for antidepressants, with lavish gifts, conference supports, foreign travels for prescribing medicos, as well as institutional corruption by influencing the criteria for diagnosis of mental illnesses. In this paper, we use in-depth interviews using grounded theory approach to explore the issues around marketization of antidepressants in Kolkata, India, seeking a deeper understanding of the factors that have led to the epidemic growth of clinical depression. Initial results show that marketization is not the sole factor responsible for this phenomenon. Socioeconomic infrastructural issues like stigma around mental health, inability to afford psychotherapy, glaring shortage in licensed healthcare professionals along with Bourdieusian power issues that put pharmacotherapy at an advantage over psychotherapy drive the unnecessary over-usage of medicines. We also discuss issues related to prestige hierarchy in medicine and its consequent effect on diagnosis of mental illness. We propose a model based on our understanding of factors that drive over-prescription and undue reliance on antidepressants. |
